Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | YPF | XOM |
|---|---|---|
| Price | $48.98 | $163.69 |
| Change today | ▼ 2.29% | ▲ 0.58% |
| Market cap | $19.26B | $673.08B |
| Return, 3 months | +8.9% | +20.9% |
| Return, year to date | +35.5% | +38.8% |
| Return, 1 year | +107.8% | +50.4% |
| P/E (TTM) | 25.9 | 21.1 |
| P/B | 1.5 | 2.6 |
| P/E percentile vs own 5y | 94th | 90th |
| Dividend yield | – | 2.49% |
| Revenue growth (YoY, latest qtr) | +41.7% | +44.1% |
| Net profit growth (YoY) | +1,977.6% | +102.4% |
| Gross margin | 35.0% | 20.6% |
| Operating margin | 17.6% | 10.7% |
| Net margin | 3.6% | 9.1% |
| Return on equity | 6.2% | 12.6% |
| Analyst target vs. price | +20.5% | +5.3% |
| Analyst buy share | 60% | 50% |
| RSI (14) | 39 | 53 |
| 30-day volatility | 31.8% | 24.7% |
| Max drawdown, 1 year | -21.2% | -20.1% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
